Economic costs of full-blown and subthreshold panic disorder
Authors:
- Neeltje BatelaanNBNeeltje Batelaan
- Filip SmitFSFilip Smit
- Ron de GraafRGRon de Graaf
- Anton van BalkomABAnton van Balkom
- Wilma VolleberghWVWilma Vollebergh
- Aartjan BeekmanABAartjan Beekman
- 1 December 2007
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 104 (1-3) , 127-136
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The Epidemiology of Panic Attacks, Panic Disorder, and Agoraphobia in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2006
- The Nottingham study of neurotic disorder: predictors of 12 year costsActa Psychiatrica Scandinavica, 2005
- Twelve-Month Use of Mental Health Services in the United StatesArchives of General Psychiatry, 2005
- Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005
- Cost of anxiety disorders in EuropeEuropean Journal of Neurology, 2005
- Panic Attack as a Risk Factor for Severe PsychopathologyAmerican Journal of Psychiatry, 2004
- Guidelines for Pharmacoeconomic StudiesPharmacoEconomics, 1997
- Canadian Guidelines for Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1996
- The November 1995 Revised Australian Guidelines for the Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1996
- Cost-of-illness studies: fact or fiction?The Lancet, 1994